Literature DB >> 30158345

Optical Coherence Tomography Predictors for Recurrent Restenosis After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.

Katsuya Miura1, Takeshi Tada1, Seiji Habara1, Akimune Kuwayama1, Takenobu Shimada1, Masanobu Ohya1, Ryosuke Murai1, Hidewo Amano1, Shunsuke Kubo1, Suguru Otsuru1, Hiroyuki Tanaka1, Yasushi Fuku1, Tsuyoshi Goto1, Kazushige Kadota1.   

Abstract

BACKGROUND: Little is known of the relationship between optical coherence tomography (OCT) findings and recurrent restenosis after paclitaxel-coated balloon (PCB) angioplasty for drug-eluting stent in-stent restenosis (DES-ISR). To identify the predictors of recurrent restenosis after PCB angioplasty, we investigated quantitative and qualitative OCT findings during PCB angioplasty for DES-ISR. Methods and 
Results: In all, 222 DES-ISR lesions treated by PCB angioplasty with OCT assessment and followed-up angiographically at 6 months were divided into restenotic and non-restenotic lesions on the basis of the presence or absence of restenosis at follow-up. There was a significantly higher proportion of the heterogeneous tissue pattern in restenotic than non-restenotic lesions (26.5% vs. 11.0%, respectively; P=0.02). The OCT-derived post-procedural minimal lumen and stent areas were significantly smaller in restenotic lesions, but the intima area was similar in both groups. Post-procedural stent underexpansion, defined as a stent diameter : size of the previous stent ratio <1.0, was more frequently observed in restenotic than non-restenotic lesions (33.3% vs. 17.4%, respectively; P=0.02). Multivariate analysis identified a heterogeneous tissue pattern (odds ratio [OR] 2.92; 95% confidence interval [CI] 1.32-6.47; P=0.006) and post-procedural stent underexpansion (OR 2.36; 95% CI 1.15-4.85; P=0.04) as independent predictors of recurrent restenosis.
CONCLUSIONS: The heterogeneous tissue pattern and insufficient post-procedural minimal lumen area, caused primarily by stent underexpansion, may be associated with restenosis after PCB angioplasty for DES-ISR.

Entities:  

Keywords:  In-stent restenosis; Optical coherence tomography; Paclitaxel-coated balloon

Mesh:

Substances:

Year:  2018        PMID: 30158345     DOI: 10.1253/circj.CJ-18-0464

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  3 in total

1.  Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis.

Authors:  Erion Xhepa; Robert A Byrne; Fernando Rivero; Andi Rroku; Javier Cuesta; Gjin Ndrepepa; Sebastian Kufner; Teresa Bastante Valiente; Salvatore Cassese; Marcos Garcia-Guimaraes; Anna Lena Lahmann; Himanshu Rai; Heribert Schunkert; Michael Joner; María José Pérez-Vizcayno; Nieves Gonzalo; Fernando Alfonso; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2019-02-19       Impact factor: 5.460

2.  Open-Label Multicenter Registry on the Outcomes of In-Stent Restenosis Treated by Balloon Angioplasty with Optical Frequency Domain Imaging in the Superficial Femoral Artery (ISLAND-SFA Study).

Authors:  Kenichi Yanaka; Akihide Konishi; Toshiro Shinke; Amane Kozuki; Hiroyuki Kawamori; Yoshiro Tsukiyama; Osamu Iida; Makoto Kadotani; Takashi Omori; Ken-Ichi Hirata
Journal:  Ann Vasc Dis       Date:  2020-09-25

Review 3.  In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches.

Authors:  Annunziata Nusca; Michele Mattia Viscusi; Francesco Piccirillo; Aurelio De Filippis; Antonio Nenna; Cristiano Spadaccio; Francesco Nappi; Camilla Chello; Fabio Mangiacapra; Francesco Grigioni; Massimo Chello; Gian Paolo Ussia
Journal:  Life (Basel)       Date:  2022-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.